CircRNAs and cancer: Biomarkers and master regulators

被引:312
|
作者
Arnaiz, Esther [1 ]
Sole, Carla [1 ]
Manterola, Lorea [1 ]
Iparraguirre, Leire [2 ]
Otaegui, David [2 ]
Lawrie, Charles H. [1 ,3 ,4 ]
机构
[1] Biodonostia Res Inst, Mol Oncol Grp, Paseo Doctor Begiristain S-N, San Sebastian 20014, Spain
[2] Biodonostia Res Inst, Multiple Sclerosis Grp, Paseo Doctor Begiristain S-N, San Sebastian 20014, Spain
[3] Univ Oxford, John Radcliffe Hosp, Radcliffe Dept Med, Oxford OX3 9DU, England
[4] Ikerbasque, Basque Fdn Sci, Maria Diaz Haroko Kalea 3, Bilbao 48013, Spain
关键词
circRNA; Biomarkers; Liquid biopsies; Non-coding RNA; CIRCULAR RNA EXPRESSION; COLORECTAL-CANCER; GASTRIC-CANCER; CELL-PROLIFERATION; LUNG-CANCER; REVEALS; GENE; TRANSCRIPTS; BIOGENESIS; MIGRATION;
D O I
10.1016/j.semcancer.2018.12.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Circular RNAs (circRNAs) are a novel class of regulatory RNAs that despite being relatively abundant have only recently begun to be explored. There are many thousands of genes that appear capable of producing circRNAs, however the function of all but a handful remain to be determined. What is emerging about these highly conserved molecules is that they play important roles in biology and cancer biology in particular. The most explored function of circRNAs is as master regulators of gene expression that act to sequester or 'sponge' other gene expression regulators, in particular miRNAs. They have also been demonstrated to function via direct modulation of transcription, and by interfering with splicing mechanisms. Although generally expressed in low abundance when compared to their linear counterparts, they are often expressed in a tissue- and developmental stage-specific manner. Coupled with their remarkable resistance to RNAse activity due to a covalent closed cyclic structure, circRNAs show great promise as novel biomarkers of cancer and other diseases. In this review we consider the current state of knowledge regarding these molecules, their synthesis, function, and association with cancer. We will also review some of the challenges that remain to be resolved if this emerging class of RNAs are really to become useful in the clinic.
引用
收藏
页码:90 / 99
页数:10
相关论文
共 50 条
  • [1] CircRNAs and lung cancer: Biomarkers and master regulators
    Di, Xin
    Jin, Xin
    Li, Ranwei
    Zhao, Min
    Wang, Ke
    LIFE SCIENCES, 2019, 220 : 177 - 185
  • [2] Plasma circRNAs as Biomarkers in Cancer
    Zhou, Qian
    Ju, Lin-Ling
    Ji, Xiang
    Cao, Ya-Li
    Shao, Jian-Guo
    Chen, Lin
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 7325 - 7337
  • [3] CircRNAs as biomarkers of cancer: a meta-analysis
    Wang, Miao
    Yang, Yuxi
    Xu, Jian
    Bai, Wen
    Ren, Xueli
    Wu, Huijian
    BMC CANCER, 2018, 18
  • [4] CircRNAs: Emerging Bladder Cancer Biomarkers and Targets
    Liang, Zhaofeng
    Guo, Wenhao
    Fang, Shikun
    Zhang, Yue
    Lu, Ling
    Xu, Wenrong
    Qian, Hui
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [5] CircRNAs as biomarkers of cancer: a meta-analysis
    Miao Wang
    Yuxi Yang
    Jian Xu
    Wen Bai
    Xueli Ren
    Huijian Wu
    BMC Cancer, 18
  • [6] Exosome-Associated circRNAs as Key Regulators of EMT in Cancer
    Amicone, Laura
    Marchetti, Alessandra
    Cicchini, Carla
    CELLS, 2022, 11 (10)
  • [7] Exosomal circRNAs in cancer: Implications for therapy resistance and biomarkers
    Lin, Zhengjun
    Ji, Yuqiao
    Zhou, Jian
    Li, Guoqing
    Liu, Weifeng
    Li, Zhihong
    Liu, Tang
    CANCER LETTERS, 2023, 566
  • [8] Roles of the Specific circRNAs as Novel Biomarkers for Prostate Cancer
    Wang, B.
    Xia, Q.
    Zheng, J.
    PANCREAS, 2020, 49 (02) : 153 - 153
  • [9] Exosomal circRNAs as novel cancer biomarkers: Challenges and opportunities
    Wang, Shuai
    Dong, Yanhan
    Gong, Anjing
    Kong, Huimin
    Gao, Jinning
    Hao, Xiaodan
    Liu, Yongmei
    Wang, Zibo
    Fan, Yuqiao
    Liu, Chengyu
    Xu, Wenhua
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2021, 17 (02): : 562 - 573
  • [10] CircRNAs in colorectal cancer: potential biomarkers and therapeutic targets
    Yuying Zhang
    Jingyan Luo
    Weikang Yang
    Wen-Chu Ye
    Cell Death & Disease, 14